ABSTRACT
<p><b>AIM</b>To investigate the transforming growth factor beta1 (TGF-beta1) and basic fibroblast growth factor (bFGF) expressions in benign prostatic hyperplasia (BPH) and the effect of beta-radiation.</p><p><b>METHODS</b>TGF-beta1 and bFGF expression was studied by means of an immunohistochemical method in nine normal prostatic (NP) tissues, 15 hyperplastic prostatic tissues and 35 hyperplastic prostatic tissues treated with 90Sr/90Y.</p><p><b>RESULTS</b>The TGF-beta1 expression in the epithelium and stroma of normal prostatic tissues was 68.2 % +/- 10.5 % and 29.7 % +/- 4.6 %, respectively, while it was 64.8 % +/- 9.3 % and 28.6 % +/- 4.1 %, respectively, in hyperplastic prostatic tissues. Compared with the controls, TGF-beta1 expression in the epithelia and stroma of BPH treated with 90Sr/90Y increased significantly (P <0.01). The bFGF expression in epithelia and stroma of normal prostatic tissues was 17.4 % +/- 3.7 % and 42.5 % +/- 6.8 %, respectively, and was 46.3 % +/- 8.2 % and 73.2 % +/- 12.1 %, respectively, in hyperplastic prostatic tissues. Compared with the controls, expressions of bFGF in the epithelia and stroma of BPH treated with a 90Sr/90Y prostatic hyperplasia applicator decreased significantly (P <0.01).</p><p><b>CONCLUSION</b>Exposure of beta-rays had noticeable effects on BPH tissues, enhancing TGF-beta1 expression and inhibiting bFGF expression.</p>
Subject(s)
Aged , Aged, 80 and over , Humans , Male , Middle Aged , Beta Particles , Case-Control Studies , Fibroblast Growth Factor 2 , Metabolism , Radiation Effects , Gene Expression , Immunohistochemistry , Prostate , Metabolism , Radiation Effects , Prostatic Hyperplasia , Metabolism , Radiotherapy , Strontium Radioisotopes , Therapeutic Uses , Transforming Growth Factor beta , Metabolism , Radiation Effects , Transforming Growth Factor beta1 , Yttrium Radioisotopes , Therapeutic UsesABSTRACT
<p><b>AIM</b>To investigate the protective effects and mechanism of IPC on myocardial ischemia/reperfusion injury.</p><p><b>METHODS</b>Effects of IPC on arrhythmia and coronary blood flow and the release of AST, CPK, LDH, SOD and LFO at different time after ischemia/reperfusion injury in rat Langendorff hearts were studied.</p><p><b>RESULTS</b>IPC decreased the release of AST, CPK and LDH and increased myocardial SOD activity and decreased LPO level. IPC also inhibited ischemia/reperfusion arrhythmias and increased coronary blood flow.</p><p><b>CONCLUSION</b>The results showed that IPC had well protective effects on myocardial ischemia/reperfusion injury.</p>